E-Mail
IMAGE: A research team at the Wyss Institute and Harvard Medical School has developed a nasal swab collection technology enabling high-throughput automated sample processing for molecular diagnosis of respiratory diseases including. view more
Credit: Wyss Institute at Harvard University
(Boston) The Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School (HMS) and the Massachusetts-based startup Rhinostics announced today that the University s sample collection swab and high-throughput automation technologies have been licensed to Rhinostics. The company will further develop and commercialize automated and multiplexed solutions for processing nasal samples from people suspected to have COVID-19 or other respiratory infectious diseases. The license was coordinated by Harvard s Office of Technology Development (OTD) in accordance with the University s commitment to the COVID-19 Technology Access Framework.
Harvard University licenses its nasal swab collection technology, developed at the Wyss Institute and Harvard Medical School, to Mass startup Rhinostics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Harvard University and Kyowa Kirin Enter Strategic Research Alliance
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.